FEATURED FINANCING STORY
INDUSTRY
Diagnostic Imaging / Nuclear Medicine / Oncology
FINANCING AMOUNT
$1.4 million
PRIMARY BUSINESS OBJECTIVE
Finance essential imaging equipment for a new treatment-center location
EQUIPMENT FINANCED
United Imaging PET/CT system
STRUCTURE
60-month financing agreement with a vendor-coordinated delayed-funding arrangement
KEY COMPLEXITY
New-location launch requiring licensing, staffing, and program buildout before the system could generate revenue
BUSINESS IMPACT
Provider’s imaging system in place ahead of the new West Coast location’s opening, supporting a treatment program built around a new-patient pipeline
Source: NFS Capital closed transaction data. Company name and identifying details not disclosed.
A specialty oncology provider opening a new treatment location on the West Coast faced a multi-step path to launch: securing state licensing, staffing a specialized clinical team, and bringing a targeted radioligand therapy program for prostate cancer and gastrointestinal tumors to full operational readiness.
The program’s core imaging system, a United Imaging PET/CT platform, couldn’t begin generating revenue until every piece of that timeline came together, creating a gap between acquisition and cash flow that a standard equipment financing request doesn’t anticipate.
NFS Capital structured a $1.4 million, 60-month financing agreement with a delayed-funding arrangement tied to the vendor relationship, allowing the provider to bring the program online ahead of the facility’s full revenue ramp rather than carrying the full cost through licensing and staffing.
The financing put the provider’s core imaging system in place ahead of the location’s opening, supporting a treatment program built around a new-patient pipeline.
NFS Capital evaluated the full picture behind the transaction: the equipment, the new-location timeline, and the vendor relationship, rather than underwriting the new location in isolation.
That full-project view made a new-market launch financeable on a timeline that matched the business, not just the equipment invoice.
New-location healthcare launches often create a timing mismatch: the equipment has to be in place before the site can generate the revenue that supports it. NFS Capital evaluates the full project (equipment, timeline, and vendor coordination) and structures funding around how it will actually come online, not around a single invoice and delivery date.
NFS CAPITAL
Because the equipment often can’t generate revenue until the facility itself is fully operational. Financing has to account for that timing gap, not just the invoice.
Yes. NFS Capital evaluates the equipment, the vendor relationship, and the location’s launch timeline together, so financing can close and equipment can be delivered ahead of the site’s full revenue ramp.
NFS Capital finances transactions from $150,000 to $20 million or more, which covers most radiation therapy, cath lab, PET/CT, and other advanced clinical imaging and treatment projects.
Financing equipment for a new treatment location or clinical program? NFS Capital works with providers to structure funding around how the project will actually come online.
